FDA Adverse Event Malfunction Summary report: N

OMNIPOD INSULIN PUMP

MDR report key: 3003399 · Received February 13, 2013

Report

Report Number
3004464228-2013-00115
Event Type
Malfunction
Date Received
February 13, 2013
Date of Event
January 14, 2013
Report Date
January 14, 2013
Manufacturer
INSULET CORPORATION
Product Code
LZG
PMA / PMN Number
K042792
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE PRODUCT WAS RETURNED FOR EVAL AND PERFORMED AS DESIGNED. NO DEFECT THAT WOULD HAVE CAUSED THE CANNULA NOT TO INSERT PROPERLY WAS FOUND. THE CUSTOMER REPORTED THAT THE CANNULA HAD DISLODGED FROM THE INFUSION SITE. THIS CONDITION COULD INTERRUPT INSULIN DELIVERY AND CONTRIBUTE TO HYPERGLYCEMIA. IT CANNOT BE CONFIRMED NOR EXCLUDED THROUGH LAB INVESTIGATION. THE OMNIPOD'S USER GUIDE WARNS "CHECK OFTEN TO MAKE SURE THE POD AND SOFT CANNULA ARE SECURELY ATTACHED AND IN PLACE. A LOOSE OR DISLODGED CANNULA MAY INTERRUPT INSULIN DELIVERY," AND "BECAUSE INSULIN PODS USE ONLY RAPID-ACTING INSULIN, USERS ARE AT INCREASED RISK FOR DEVELOPING HYPERGLYCEMIA (HIGH BLOOD GLUCOSE) IF INSULIN DELIVERY IS INTERRUPTED. IF IT IS UNTREATED, SEVERE HYPERGLYCEMIA CAN QUICKLY LEAD TO DIABETIC KETOACIDOSIS (DKA). DKA CAN CAUSE BREATHING DIFFICULTIES, SHOCK, COMA, OR DEATH. IF INSULIN DELIVERY IS INTERRUPTED FOR ANY REASON, YOU MAY NEED TO REPLACE THE MISSING INSULIN -- USUALLY WITH AN INJECTION OF RAPID-ACTING INSULIN. ASK YOUR HEALTHCARE PROVIDER FOR INSTRUCTIONS ON HANDLING INTERRUPTED INSULIN DELIVERY." LOT QUALIFICATION RECORDS WERE REVIEWED, AND THE PRODUCT LOT MET ALL ACCEPTANCE CRITERIA.

Description of Event or Problem · 1

THE CUSTOMER¿S MOTHER REPORTED THAT THE CANNULA WAS INSERTED CORRECTLY THE NIGHT BEFORE THE EVENT. SHE STATED THAT THE NEXT NIGHT, THE PDM WAS READING HIGH (>500 MG/DL) AND THAT THE CANNULA HAD BECOME DISLODGED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
63805 OMNIPOD INSULIN PUMP PUMP, INFUSION, INSULIN LZG INSULET CORPORATION 11200 L30990

Patients

Seq Age Sex Outcome Treatment
1 13 YR